Heath Ledger

Typically blaming the individual ( patient )

Who was prescribing or giving him RX ?

He had multiple RX given by Drs in varied parts of the world .

Let’s talk about his extreme work and travel load; his body clock was wayyyyyy off .

Health was very vulnerable and induced in to drugging legally by medical professions

1st Do NO Harm

Heath’s death really affected me , for I had watched Broke Back Mountain and witnessed a very beautiful soul 💯❤️


Targeted Individuals-Varied means of Attacks AbuseAssault

Let’s not forget what Dr. Breggin wrote about lithium, decades ago:

“Today patients and the public frequently are told that lithium carbonate is a harmless metallic salt found ‘naturally’ in the body and that its function in manic-depressive disorder is similar to the function of insulin in diabetes.

None of this is true, except that it is a metallic salt found in nature. So is lead. Like lead, it is a toxic metal with no known function in the body. Like lead, it appears in traces in the body simply because it’s in the environment.”


Lithium Use leads to Chronic Kidney Disease

Lithium is a metal ; I’m allergic to metals yet Dr did not pick up on this though I listed RX I could not take .

It ravaged my body and when I complained the ” coated ” version of Lithium was prescribed .

I had prior kidney issues . I had been diagnosed with IBS which I now treat as ” leaky gut ” .

Lithium can generate brain cell growth as I discussed with my last Psychiatrist . She thought I was brilliant and told me I should become a Dr !

We tried 3 mg of Lithium and signs of toxicity quickly followed through out my body and I quit it .

I recalled the blood test and lethargic results of Lithium prescribed by an accredited, founding father of a psychiatrist who by luck did not kill me .

13 years of my medical records bear out an ineptitude that is mind blowing .

He has retired . He has a debilitating disease he has lived and worked with for decades .

Lithium is commonly prescribed to people diagnosed with bipolar disorder. The drug is often continued indefinitely as a “maintenance” treatment because it is theorized to have a preventive effect as a “mood stabilizer.” However, it requires constant monitoring because lithium toxicity can damage several body systems and even lead to death.

Now, a new study has demonstrated that lithium use causes chronic kidney disease at an increased rate, particularly in those who used the drug long-term.

“Patients treated with lithium are at increased risk of chronic kidney disease after long-term exposure,” the researchers write.

The researchers note that more than half of those who begin taking lithium discontinue the drug because of its adverse effects. Lithium levels must be measured every three to six months because the drug can accumulate in the brain and cause permanent brain damage (“neural toxicity”). In addition, thyroid damage is common, with those taking lithium about six times more likely to have hypothyroidism than the general population. Another concern of note is the risk of severe kidney damage. About 20% of those taking lithium experience nephrogenic diabetes insipidus, and, in some cases, the kidney damage may be irreversible.

The current study was published in the top-tier psychiatric journal Lancet Psychiatry, and the research was led by Filip Fransson at Umeå University, Sweden.

Lithium Use Leads to Chronic Kidney Disease


Drug Samples Cost

A new commentary published in the Journal of Pharmaceutical Policy and Practice reports that branded drug samples handed out by the pharmaceutical industry increase drug costs for everyone and compromise patient safety.

Emily Couvillon Alagha and Adriane Fugh-Berman present a collection of condemning research around branded drug samples that contradicts prevailing physician beliefs about the benefits of the practice. According to the authors, research has found that only drugs with the highest profit margin are sampled, that patients receiving samples have higher overall out-of-pocket costs for their healthcare, and that those with the most financial need are the least likely to receive samples.

This commentary joins a chorus of research that shows the pharmaceutical industry is willing to sacrifice public health for profits. The authors write:

“Samples are not a charitable activity but are instead a highly effective form of drug marketing. Samples remain the largest marketing investment among most companies. Pharmaceutical companies would not invest so much in optimizing sampling distribution if they did not see a return on investment from these strategies.”

Drug Samples Increase Healthcare Costs and Compromise Patient Safety


Lithium & a Troubled Teen with No where to go

I was prescribed Lithium with prior kidney issues

I was prescribed Lithium though I’m highly allergic

to metals

I was prescribed Lithium with complaints of raging


I was prescribed a coated version of Lithium after


I was prescribed Lithium by a foundation of psychiatry

I was prescribed Lithium , had all the signs of toxicity

and my partner was ” not interested ”

* partner nor doctor were interested in my well being

My parents were sold a bill of goods. They believed they had no choice, and this was a matter of life and death.


Serotonin Zombies

The Serotonin Zombie: Authors of New Study Try to Breathe New Life into the Dead

However, the results of the study actually support the conclusion that low serotonin is not a cause of depression.

The researchers studied three questions:

1. They asked whether people with depression had lower serotonin than healthy controls at baseline—and found that they did not.

2. They asked whether serotonin levels correlate with severity of depression—and found that they did not.

3. Finally, they asked whether people with depression dosed with an amphetamine would have less change in serotonin than people without depression dosed with an amphetamine—and here they found a statistically significant effect. But their own data shows that 10 of the 11 people with depression overlapped with healthy controls—the result was driven by one outlier.

Even The Guardian has somehow spun this into “clear evidence” that depression and serotonin are related.


Depression stats are still high , despite all the “ advanced treatments “

Between 1987 and 2007, the number of people receiving treatment for depression in the United States increased fourfold (and has continued to rise more gradually since). However, the prevalence of depression either stayed the same—or may have even increased—during that time. Researchers call this the “treatment-prevalence paradox” (TPP).

* Browse through a DSM for all the codes that allow billing to insurance and you’ll find every human emotion , every sickness , every disease and you can bet the pharmacy has an antidepressant for that particular issue .

No science. Read the facts of how efficiently testing is done or not.

Ready of the kin ship between FDA who usually rewards the best show , not the best product.

The horrific loss of life and families erased as mine was began in 1987 with the huge push to diagnosis bipolar which presented in varied ways .

Their eyes are wide shut about these side effects and society accepted , the law embraced the all knowing wizards of Pharma and suicide was normalized by many especially 80’s

Ignoring thus supporting abuse Knowing thus supporting the trauma .

For these reasons and more , having personally exited that matrix , I’m aware there are many like I was ; induced into a state of Ill health and toxic mind and endured 5 years of neglect , abandonment , having no interest in my life , before leaving for another 20 year period aligned with his twin .

Learning nothing , his shadow is depressive , and I’m eager to complete business and no contact ever .

Coming to and regaining , renewing my essence was hellish in many respects but invaluable to my healing process .

Blessings& Peace ❤️☮️

Dona Luna 🐸

Now, in a new study, researchers review the seven possible explanations for this—and the evidence for and against each one. The study was led by Johan Ormel at the University of Groningen, The Netherlands, and published in Clinical Psychology Review.

Ormel and his co-authors explain:

“The increased availability of effective treatments should shorten depressive episodes, reduce relapses, and curtail recurrences. Combined, these treatment advances unequivocally should result in lower point-prevalence estimates of depression. Have these reductions occurred? The empirical answer clearly is NO.”

Despite More Treatments for Depression, Prevalence Doesn’t Decrease—Why?